Alexion Pharmaceuticals, Inc. (ALXN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
124.51-2.71 (-2.13%)
At close: 4:00 PM EDT
People also watch:
REGNBMRNVRTXBIIBCELG
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open127.22
Prev Close127.22
Bid124.50 x 200
Ask142.49 x 100
Day's Range124.21 - 127.64
52wk Range110.56 - 193.45
1y Target EstN/A
Market Cap27.92B
P/E Ratio (ttm)312.84
Beta1.25
Volume1,288,553
Avg Vol (3m)1,628,264
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube19 hours ago

    Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ALXN-US : September 26, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Alexion Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more (Read more...)

  • Barrons.com3 days ago

    [$$] Biotech Is Cheaper Than Big Pharma

    After years of skyrocketing stock prices fueled by blockbuster drug sales, Big Biotech is now seen by investors as being no better, and perhaps worse, than Big Pharma. You are getting good pipeline assets at a much bigger discount,” says Marshall Gordon, manager of the ClearBridge Global Health Care Innovations fund.

  • Investopedia3 days ago

    Alexion Gets U.K. Approval for High-Cost Drug (ALXN)

    Though user base is small for this rare disease, the high annual cost of up to $2 million offers attractive commercials for Alexion.